Literature DB >> 31919068

Multiple myeloma with extensive AL amyloidosis presenting as chronic diarrhoea.

William Kogler1, Catarina Canha2, Raafat Makary3, Reeba Omman3, Carmen Liliana Isache2.   

Abstract

We present a 52-year-old man admitted to the hospital with diarrhoea and lower extremity weakness ongoing for the past 3 months. The patient was found to have malabsorptive diarrhoea, hypoproliferative anaemia and renal insufficiency with proteinuria. Extensive workup was performed including a bone marrow biopsy with 20% plasma cells, renal and duodenal biopsies with Congo-red staining revealed amyloid deposition. The patient was diagnosed with multiple myeloma and amyloidosis with gastrointestinal, kidney and nerve involvement explaining his presentation with diarrhoea, renal insufficiency and weakness. Throughout his admission, there were incidental findings of asymptomatic hypoglycaemia (serum blood glucose <40 mg/dL), which was later found to be caused by anti-insulin monoclonal antibodies produced by the neoplastic plasma cells. This is an extremely rare manifestation of multiple myeloma with only a few cases reported in the literature. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); malabsorption; malignant and benign haematology; nephrotic syndrome; proteinurea

Mesh:

Year:  2020        PMID: 31919068      PMCID: PMC6954776          DOI: 10.1136/bcr-2019-232934

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

Review 2.  Amyloid neuropathies.

Authors:  Susan C Shin; Jessica Robinson-Papp
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

3.  Hypoglycemia due to monoclonal anti-insulin antibody in a patient with multiple myeloma.

Authors:  João Tadeu Damian Souto Filho; Maria Fernanda Fernandes Duarte Costa; Gabriela Assis Rangel de Abreu; Laís Mesquita Caetano; Vanessa Soares Batista; Douglas Dias E Silva
Journal:  Ann Hematol       Date:  2016-05-23       Impact factor: 3.673

Review 4.  Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?

Authors:  N J Bahlis; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2006-05-22       Impact factor: 5.483

Review 5.  Amyloid nephropathy.

Authors:  Mazdak A Khalighi; W Dean Wallace; Miguel F Palma-Diaz
Journal:  Clin Kidney J       Date:  2014-03-13

Review 6.  Gastrointestinal Amyloidosis: Review of the Literature.

Authors:  Kyle Rowe; Jon Pankow; Fredy Nehme; William Salyers
Journal:  Cureus       Date:  2017-05-08

Review 7.  Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives.

Authors:  Shayna Sarosiek; Vaishali Sanchorawala
Journal:  J Blood Med       Date:  2019-10-23

Review 8.  Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.

Authors:  Kenshi Suzuki
Journal:  Clin Exp Nephrol       Date:  2012-09-13       Impact factor: 2.801

Review 9.  Al amyloidosis.

Authors:  Estelle Desport; Frank Bridoux; Christophe Sirac; Sébastien Delbes; Sébastien Bender; Béatrice Fernandez; Nathalie Quellard; Corinne Lacombe; Jean-Michel Goujon; David Lavergne; Julie Abraham; Guy Touchard; Jean-Paul Fermand; Arnaud Jaccard
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

10.  Symptomatic primary (Al) amyloidosis of the stomach and duodenum.

Authors:  Reidar Fossmark; Espen Skarsvåg; Harald Aarset; Henrik Hjorth-Hansen; Helge L Waldum
Journal:  Case Rep Gastrointest Med       Date:  2013-02-25
View more
  1 in total

1.  Chronic Diarrhea as the Presenting Feature of Amyloidosis with Multiple Myeloma: A Case Report Diagnosed by a Myocardial Biopsy.

Authors:  Shinsuke Otagiri; Sae Nakajima; Takehiko Katsurada; Kensuke Sakurai; Kana Yamanashi; Takahide Ara; Emi Takakuwa; Tomoko Mitsuhashi; Naoya Sakamoto
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.